In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, Eris Lifesciences has informed about the schedule of Analyst / Institutional Investor Meeting on Monday May 26, 2025. The company will be referring to publicly available documents for discussions during interaction in the meeting and no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. The unedited audio/video recording of the full meeting will be accessible at the Registered Office of the Company for the purpose of regulators' inspection, if and when needed.
The above information is a part of company’s filings submitted to BSE.
